mRNA · Vaccines
Strategies for Ensuring Biomanufacturing Resilience for Biologics
There is consensus among the global health community that long-term collaboration in resilient biomanufacturing capacity and supply chains…
Oliver Prince, Ph.D.
Oliver Prince, Ph.D. is a Senior Consultant, supporting vaccine and monoclonal antibodies within
Merck KGaA, Darmstadt, Germany's
MilliporeSigma’s
bioprocessing group. Currently, he focuses on “connecting dots” by leading strategic initiatives, supporting go-to-market strategies, as well as supporting customers to build and optimize their manufacturing processes.
